Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone
Phase of Trial: Phase IV
Latest Information Update: 18 Jul 2017
At a glance
- Drugs Methylnaltrexone bromide (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Acronyms RILAX
- 29 Mar 2017 Status changed from recruiting to discontinued.
- 20 Mar 2017 Planned End Date changed from 1 Sep 2016 to 1 Sep 2017.
- 20 Mar 2017 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2017.